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Reply
Kwangsik Nho, PhD and Andrew J. Saykin, PsyD
Department of Radiology and Imaging Sciences, Indiana Alzheimer Disease Center, Indiana 
University School of Medicine, Indianapolis, IN
We appreciate Dr. Jiang’s and Liu’s interest in our recent study, where we reported that the 
minor allele of a missense variant (rs3796529) in the REST gene may be protective for rate 
of hippocampal volume loss in individuals with mild cognitive impairment (MCI) with 
APOE ε3/ε3 genotype.1 In their letter, the authors reported that rs3796529 was not 
significantly associated with the volumes of 7 subcortical regions of human brain 
determined by magnetic resonance imaging using data from the large-scale genome-wide 
association study (GWAS) summary statistics from the Enhancing Neuro Imaging Genetics 
through Meta-Analysis (ENIGMA) consortium.2
The authors’ negative findings in contrast to the association we reported may be due to 
numerous differences, including the following factors. First, the ENIGMA consortium 
included patients diagnosed with anxiety, Alzheimer disease (AD), epilepsy, major 
depressive disorder, or schizophrenia (>20% of the discovery participants).2 Although the 
presence of any diagnosis was used as a covariate in ENIGMA, various neurologic and 
psychiatric disorders may have differential effects on brain structure volumes, and this may 
have averaged out any influence of the REST variant. In contrast, the discovery samples in 
our study included only individuals with MCI, often representing a prodromal stage of AD. 
Second, the participants of the ENIGMA consortium were aged 9 to 97 years, covering most 
of the human lifespan,2 whereas the participants in our study were older adults (mean age = 
74.4 years, range = 57.8–85.7 years). Finally, it should be noted that our sample included 
only participants with APOE ε3/ε3 genotype, as it was designed to identify variants 
independent of the well-established APOE ε4 AD risk factor. In contrast, Dr. Jiang and Liu 
examined GWAS summary statistics obtained using all ENIGMA samples regardless of 
APOE ε4 genotype.2
We believe Dr. Jiang’s and Liu’s negative findings are interesting yet should be interpreted 
with caution given the marked differences in sample characteristics and study design from 
the Alzheimer’s Disease Neuroimaging Initiative report that addressed a very specific older 
adult population. The large sample size in ENIGMA should not dissuade further studies, 
which we believe are warranted to more precisely characterize the association of this and 
other REST variants with subcortical brain structure volumes in cognitively normal older 
adults as well as those with neurodegenerative disorders.
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